Vimarsana
Biggest News Aggregation in the World

Page 2 - Submit Comments News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Submit Comments. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Submit Comments Today - Breaking & Trending Today

Enforcement Policy for Certain In Vitro Diagnostic Devices for Immediate Public Health Response in the Absence of a Declaration under Section 564 - Vimarsana News

Enforcement Policy for Certain In Vitro Diagnostic Devices for Immediate Public Health Response in the Absence of a Declaration under Section 564

This draft guidance describes an enforcement policy for certain IVDs for immediate public health response in the absence of a declaration under section 564.

Source: fda.gov
Cancer Clinical Trial Eligibility Criteria: Performance Status - Vimarsana News

Cancer Clinical Trial Eligibility Criteria: Performance Status

Guidance for Industry, IRBs, and Clinical Investigators

Source: fda.gov
Cancer Clinical Trial Eligibility Criteria: Laboratory Values - Vimarsana News

Cancer Clinical Trial Eligibility Criteria: Laboratory Values

Guidance for Industry, IRBs, and Clinical Investigators

Source: fda.gov
Cancer Clinical Trial Eligibility Criteria: Washout Periods and Concomitant Medications - Vimarsana News

Cancer Clinical Trial Eligibility Criteria: Washout Periods and Concomitant Medications

Guidance for Industry, IRBs, and Clinical Investigators

Source: fda.gov
Promotional Labeling and Advertising Considerations for Prescription B - Vimarsana News

Promotional Labeling and Advertising Considerations for Prescription B

Guidance for Industry Advertising

Source: fda.gov